INTEGRA LIFESCIENCES HOLDINGS CORP Amortization
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Amortization of $27.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2026-07-29
- INTEGRA LIFESCIENCES HOLDINGS CORP amortization for the quarter ending 2026-06-30 was $27.00M, a 0.75% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP amortization for the quarter ending 2026-03-31 was $27.00M, a 1.89% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP amortization for the quarter ending 2025-12-31 was $27.00M, a 1.89% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP amortization for the quarter ending 2025-09-30 was $26.90M, a 5.08% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP amortization for fiscal 2025 was $107.10M, a 1.81% increase from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP amortization for fiscal 2024 was $105.20M, a 27.05% increase from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP amortization for fiscal 2023 was $82.80M, a 5.75% increase from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP amortization for fiscal 2022 was $78.30M, a 6.00% decline from fiscal 2021.
| Period end | Amortization 3 month | Amortization 3 month as first filed | Amortization 6 month | Amortization 9 month | Amortization 12 month | Amortization 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27.00M 10-Q · filed 2026-07-29 | $54.00M 10-Q · filed 2026-07-29 | $81.00M derived: sum of 3 quarters · filed 2026-07-29 | $107.90M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2026-03-31 | $27.00M 10-Q · filed 2026-05-05 | $54.00M derived: sum of 2 quarters · filed 2026-05-05 | $80.90M derived: sum of 3 quarters · filed 2026-05-05 | $107.70M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-12-31 | $27.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $53.90M derived: sum of 2 quarters · filed 2026-02-26 | $80.70M derived: sum of 3 quarters · filed 2026-07-29 | $107.10M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $26.90M 10-Q · filed 2025-10-30 | $53.70M derived: sum of 2 quarters · filed 2026-07-29 | $80.10M 10-Q · filed 2025-10-30 | $106.70M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-06-30 | $26.80M 10-Q · filed 2026-07-29 | $53.30M 10-Q · filed 2026-07-29 | $79.80M derived: sum of 3 quarters · filed 2026-07-29 | $105.40M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-03-31 | $26.50M 10-Q · filed 2026-05-05 | $53.00M derived: sum of 2 quarters · filed 2026-05-05 | $78.60M derived: sum of 3 quarters · filed 2026-05-05 | $104.00M derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | $26.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $52.10M derived: sum of 2 quarters · filed 2026-02-26 | $77.50M derived: sum of 3 quarters · filed 2026-02-26 | $105.20M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $25.60M 10-Q · filed 2025-10-30 | $51.00M derived: sum of 2 quarters · filed 2025-10-30 | $78.70M 10-Q · filed 2025-10-30 | $99.40M derived: sum of 4 quarters · filed 2025-10-30 | ||
| 2024-06-30 | $25.40M 10-Q · filed 2025-07-31 | $53.10M 10-Q · filed 2025-07-31 | $73.80M derived: sum of 3 quarters · filed 2025-07-31 | $94.70M derived: sum of 4 quarters · filed 2025-07-31 | ||
| 2024-03-31 | $27.70M 10-Q · filed 2025-05-05 | $48.40M derived: sum of 2 quarters · filed 2025-05-05 | $69.30M derived: sum of 3 quarters · filed 2025-05-05 | $89.90M derived: sum of 4 quarters · filed 2025-05-05 | ||
| 2023-12-31 | $20.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $41.60M derived: sum of 2 quarters · filed 2025-02-25 | $62.20M derived: sum of 3 quarters · filed 2025-02-25 | $82.80M 10-K · filed 2025-02-25 | ||
| 2023-09-30 | $20.90M 10-Q · filed 2024-11-04 | $41.50M derived: sum of 2 quarters · filed 2024-11-04 | $62.10M 10-Q · filed 2024-11-04 | $81.70M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-06-30 | $20.60M 10-Q · filed 2024-07-29 | $41.30M 10-Q · filed 2024-07-29 | $60.80M derived: sum of 3 quarters · filed 2025-02-25 | $80.00M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-03-31 | $20.60M 10-Q · filed 2024-05-06 | $40.20M derived: sum of 2 quarters · filed 2025-02-25 | $59.40M derived: sum of 3 quarters · filed 2025-02-25 | |||
| 2022-12-31 | $19.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $38.80M derived: sum of 2 quarters · filed 2025-02-25 | $78.30M 10-K · filed 2025-02-25 | |||
| 2022-09-30 | $19.20M 10-Q · filed 2023-10-25 | $58.70M 10-Q · filed 2023-10-25 | ||||
| 2021-12-31 | $83.30M 10-K · filed 2024-02-28 | |||||
| 2020-12-31 | $74.50M 10-K · filed 2023-02-22 | |||||
| 2019-12-31 | $72.80M 10-K · filed 2022-02-24 | |||||
| 2018-12-31 | $71.60M 10-K · filed 2021-02-23 | |||||
| 2017-12-31 | $52.80M 10-K · filed 2020-02-21 | |||||
| 2016-12-31 | $41.50M 10-K · filed 2019-02-26 | |||||
| 2015-12-31 | $32.20M 10-K · filed 2018-03-01 | |||||
| 2014-12-31 | $22.70M 10-K · filed 2017-02-23 | $31.80M 10-K · filed 2015-02-27 | ||||
| 2013-12-31 | $11.20M 10-K · filed 2016-02-26 | $19.40M 10-K · filed 2014-02-27 | ||||
| 2012-12-31 | $25.10M 10-K · filed 2015-02-27 | |||||
| 2012-06-30 | $4.65M 10-Q · filed 2012-07-31 | $9.37M 10-Q · filed 2012-07-31 | ||||
| 2012-03-31 | $4.72M 10-Q · filed 2012-07-31 | -$4.72M 10-Q · filed 2012-04-26 | ||||
| 2011-12-31 | $24.60M 8-K · filed 2014-06-20 | |||||
| 2011-06-30 | $4.05M 10-Q · filed 2012-07-31 | $7.06M 10-Q · filed 2012-07-31 | ||||
| 2011-03-31 | $3.01M 10-Q · filed 2012-07-31 | -$3.01M 10-Q · filed 2012-04-26 | ||||
| 2010-12-31 | $17.90M 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |